|
|
|
|
Lifeward Ltd (NASDAQ: LFWD) |
|
Price: $1.6400
$-0.17 
-9.392%
|
| Day's High:
| $1.85
| Week Perf:
| 5.13 %
|
| Day's Low: |
$ 1.61 |
30 Day Perf: |
0.61 % |
| Volume (M): |
399 |
52 Wk High: |
$ 7.70 |
| Volume (M$): |
$ 654 |
52 Wk Avg: |
$3.65 |
| Open: |
$1.85 |
52 Wk Low: |
$1.41 |
|
|
| Market Capitalization (Millions $) |
14 |
| Shares
Outstanding (Millions) |
9 |
| Employees |
50 |
| Revenues (TTM) (Millions $) |
18 |
| Net Income (TTM) (Millions $) |
-14 |
| Cash Flow (TTM) (Millions $) |
-22 |
| Capital Exp. (TTM) (Millions $) |
0 |
Lifeward Ltd
Company Address: 200 Donald Lynch Blvd. Marlborough 1752
Company Phone Number: 251.1154 Stock Exchange / Ticker: NASDAQ LFWD
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Management Announcement
Published Mon, Jan 13 2025 1:30 PM UTC
Lifeward Ltd. (Nasdaq: LFWD), a key player in the healthcare sector focused on rehabilitation and recovery solutions, recently issued a year-end open letter to shareholders detailing its operational and commercial priorities for 2025. The letter provides insights into the company s recent performance, financial health, and strategic direction, signaling a robust outlook for ...
|
| Shares
Published Tue, Jan 7 2025 1:06 PM UTC
Lifeward Ltd. Expands Horizons with Strategic Capital Raise: Implications for Shareholders...
|
| Product Service News
Published Tue, Sep 24 2024 9:00 PM UTC
In a significant move set to redefine their market presence, Lifeward GmbH has announced the launch of direct sales for the AlterG product line throughout Germany. This strategic shift marks a pivotal moment not only for Lifeward but also for AlterG a brand renowned for its innovative rehabilitation and performance technologies.By opting for a direct-to-consumer model, Lifew...
|
| Management Changes
Published Tue, Sep 10 2024 12:31 PM UTC
In a move that underscores its commitment to pioneering advancements in spinal injury treatment and rehabilitation technology, Lifeward has made two significant announcements set to shape the landscape of healthcare. The appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research and the introduction of the AlterG NEO device are indicative of Lifeward...
|
| Product Service News
Published Wed, Jun 26 2024 12:30 PM UTC
Introducing AlterG NEO: Revolutionizing Physical Rehabilitation and Athletic TrainingLifeward, a pioneer in innovative healthcare technology, recently unveiled its latest addition to the highly acclaimed AlterG Anti-Gravity product line - the AlterG NEO. This groundbreaking device combines a user-friendly design with trusted Anti-Gravity technology, providing precise and con...
|
| Per Share |
Current |
| Earnings (TTM) |
-1.58 $ |
| Revenues (TTM) |
2.07 $
|
| Cash Flow (TTM) |
- |
| Cash |
1.22 $
|
| Book Value |
3.87 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-1.58 $
|
| Revenues (TTM) |
2.07 $ |
| Cash Flow (TTM) |
- |
| Cash |
1.22 $
|
| Book Value |
3.87 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
On May 15 2024 the Lifeward Ltd provided following guidance
The first quarter of 2024 proved to be a successful period for Rewalk Robotics Ltd., with a reported revenue of $5.3 million. This marked a significant increase of 340% compared to the revenue reported in the firs...
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
18.94% 